What Does a Rheumatologist Do

Rheumatologists are physicians who specialize in diagnosing and managing diseases of the joints, muscles, bones, and immune system — a clinical territory spanning more than 100 distinct conditions recognized by the American College of Rheumatology (ACR). The scope of rheumatology intersects directly with internal medicine, immunology, and musculoskeletal medicine, making the rheumatologist a central figure for patients whose symptoms cross multiple organ systems. Understanding what a rheumatologist does clarifies when a primary care referral is appropriate and how long-term disease management is structured. The rheumatology authority index provides a broader orientation to the field for readers new to the specialty.

Definition and Scope

A rheumatologist is a physician who has completed medical school, a 3-year internal medicine or pediatrics residency, and an additional 2- to 3-year fellowship in rheumatology — for a minimum of 9 years of post-secondary training before independent practice. The American Board of Internal Medicine (ABIM) administers the certifying examination for rheumatology subspecialty status; board certification signals that a physician has passed a standardized competency assessment in addition to completing supervised training.

The clinical domain governed by the specialty is defined by three overlapping categories:

Inflammatory arthritis — conditions driven by immune dysregulation, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
Systemic autoimmune disease — disorders affecting connective tissue and multiple organ systems, including lupus, scleroderma, Sjögren's syndrome, and vasculitis
Crystal and metabolic arthropathies — conditions arising from abnormal deposition of crystals in joints, most prominently gout

The ACR's classification criteria — published in peer-reviewed journals and maintained through the organization's clinical practice guidelines — establish the diagnostic thresholds rheumatologists use to differentiate these categories. Regulatory oversight of rheumatology practice in the United States falls under state medical licensing boards, while the Centers for Medicare and Medicaid Services (CMS) defines reimbursement codes that structure how rheumatology services are billed and documented.

How It Works

A rheumatology evaluation follows a structured sequence. The first visit typically involves a detailed history covering symptom onset, pattern of joint involvement, morning stiffness duration, family history of autoimmune disease, and prior medication trials. The rheumatologic examination then assesses joint swelling, tenderness, range of motion, skin findings, and extra-articular signs such as oral ulcers or dry eyes.

Laboratory testing forms the second major diagnostic pillar. Standard panels for new rheumatology patients frequently include:

Antinuclear antibody (ANA) titer and pattern
Rheumatoid factor and anti-CCP antibody
Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as inflammatory markers
Uric acid for suspected crystal arthropathy
Complement levels and expanded autoantibody panels when systemic lupus or vasculitis is suspected
HLA-B27 genetic marker when spondyloarthropathy is on the differential

Imaging rounds out the diagnostic workup. Plain radiographs remain the baseline modality, but musculoskeletal ultrasound — increasingly used at the point of care — can detect synovitis and erosions not visible on X-ray. Imaging in rheumatic disease encompasses MRI, which is particularly sensitive for early sacroiliitis in ankylosing spondylitis.

Once a diagnosis is established, rheumatologists manage treatment over long time horizons. Disease-modifying antirheumatic drugs (DMARDs) such as methotrexate are the foundation of inflammatory arthritis treatment; biologic therapies targeting specific immune pathways (TNF-alpha, IL-6, IL-17, and others) are added when conventional DMARDs are insufficient. JAK inhibitors represent a third category of targeted therapy. The U.S. Food and Drug Administration (FDA) regulates approval of all these agents, and the FDA's MedWatch program tracks adverse event reporting post-approval.

Common Scenarios

Rheumatologists encounter a predictable set of clinical presentations, though the diagnostic path for each varies considerably.

Symmetrical small-joint inflammation — swelling and stiffness in the metacarpophalangeal and proximal interphalangeal joints, worse after prolonged rest, is a hallmark presentation for rheumatoid arthritis. Morning stiffness lasting more than 45 minutes differentiates inflammatory from mechanical joint disease.

Positive autoimmune laboratory result — a primary care physician who orders an ANA panel and receives a positive result at a titer of 1:160 or higher will typically refer to rheumatology. The rheumatologist then contextualizes the result within the full clinical picture, since positive ANA results occur in approximately 5% of the healthy general population (ACR position statement on ANA testing).

Acute monoarthritis — sudden-onset intense joint pain, redness, and warmth in a single joint — particularly the first metatarsophalangeal joint — is the classic presentation of gout. Joint aspiration with polarized light microscopy to identify urate crystals confirms the diagnosis.

Multisystem symptoms — fatigue, unexplained muscle pain, oral ulcers, photosensitive rash, and renal involvement in a young woman constitute the pattern that prompts evaluation for lupus under the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.

Pregnancy and rheumatic disease represents a high-complexity scenario: several immunosuppressive agents used in rheumatology carry teratogenic risk classified by the FDA, requiring medication adjustment before and during gestation.

Decision Boundaries

Rheumatology occupies a distinct niche relative to adjacent specialties, and understanding its limits clarifies appropriate referral logic.

Rheumatology versus orthopedics: Orthopedic surgeons address structural joint damage — cartilage loss, ligament tears, fractures — that requires procedural or surgical intervention. Rheumatologists manage the underlying inflammatory or metabolic process driving that damage. The distinction is detailed further at rheumatology vs orthopedics. A patient with rheumatoid arthritis who needs a joint replacement is managed jointly: the rheumatologist controls disease activity perioperatively; the orthopedic surgeon performs the procedure.

Rheumatology versus neurology: Fibromyalgia — characterized by widespread musculoskeletal pain, fatigue, and cognitive difficulty without objective inflammation — is managed by rheumatologists despite having a central sensitization mechanism more akin to neurological conditions. The ACR 2010 Preliminary Diagnostic Criteria for Fibromyalgia define it by a Widespread Pain Index score of 7 or higher combined with a Symptom Severity Scale score of 5 or higher (or WPI of 3–6 with SSS of 9 or higher).

Pediatric rheumatology: Juvenile idiopathic arthritis and pediatric lupus fall within pediatric rheumatology, a subspecialty requiring additional fellowship training beyond adult rheumatology. The American Board of Pediatrics (ABP) and ABIM each offer certifying pathways.

Conditions outside rheumatology scope: Osteoarthritis — cartilage degeneration without primary immune-mediated inflammation — is managed in primary care or orthopedics for most patients; rheumatologists are consulted only when distinguishing osteoarthritis from inflammatory arthritis is diagnostically uncertain. Infectious arthritis, once confirmed by culture, transfers primarily to infectious disease management.

The regulatory context for rheumatology governs how these practice boundaries are codified in licensing standards, institutional credentialing, and CMS specialty designations — a framework that shapes how rheumatologists document, bill, and coordinate care across the health system.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)